These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4876300)

  • 21. Pharmacotherapy of depression--a critical review.
    Ban TA
    Psychosomatics; 1975; 16(1):17-20. PubMed ID: 1101282
    [No Abstract]   [Full Text] [Related]  

  • 22. The investigation of adrenergic metabolism with 7H3-norepinephrine in psychiatric disorders. II. Temporal changes in the distribution of urinary tritiated metabolites in affective disorders.
    Rosenblatt S; Chanley JD; Leighton WP
    J Psychiatr Res; 1969 May; 6(4):321-33. PubMed ID: 4307103
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolism of norepinephrine in depressions. Differences and effects of therapies.
    Rosenblatt S; Chanley JD
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:50-60. PubMed ID: 5937839
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
    Tyce GM; Muenter MD; Owen CA
    Mayo Clin Proc; 1970 Sep; 45(9):645-56. PubMed ID: 5311767
    [No Abstract]   [Full Text] [Related]  

  • 25. Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism.
    Muscettola G; Goodwin FK; Potter WZ; Claeys MM; Markey SP
    Arch Gen Psychiatry; 1978 May; 35(5):621-5. PubMed ID: 365126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of reserpine and dihydrazinophthalazine on cerebrospinal fluid and blood catecholamines in the hypertensive disease.
    Ciplea A; Bubuianu G
    Rev Roum Physiol; 1969; 6(4):267-74. PubMed ID: 4926779
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on urinary excretion of catecholamines in hyperthyroidism].
    Kimura T; Inoue K; Adachi T; Oikawa R; Katsumata A
    Nihon Naibunpi Gakkai Zasshi; 1969 Feb; 44(11):1222-31. PubMed ID: 4182360
    [No Abstract]   [Full Text] [Related]  

  • 28. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison [proceedings].
    Quitkin FM; Kane JM; Rifkin A; Ramos-Lorenzi JR; Saraf K; Howard A; Klein DF
    Psychopharmacol Bull; 1981 Jan; 17(1):142-4. PubMed ID: 7015396
    [No Abstract]   [Full Text] [Related]  

  • 29. Imipramine pamoate in depression.
    Doyle LN
    Psychosomatics; 1975; 16(3):129-31. PubMed ID: 1103212
    [No Abstract]   [Full Text] [Related]  

  • 30. Imipramine response in deluded depressive patients.
    Quitkin F; Rifkin A; Klein DF
    Am J Psychiatry; 1978 Jul; 135(7):806-11. PubMed ID: 352160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation between vanilyl mandelic acid and 5-hydroxyindoleacetic acid excretion in a patient with a carcinoid tumour.
    Marshall PB
    J Pharm Pharmacol; 1966 Nov; 18(11):764-5. PubMed ID: 4382061
    [No Abstract]   [Full Text] [Related]  

  • 32. [ELIMINATION OF THE PRINCIPAL URINARY METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS. CLINICO-BIOLOGICAL CORRELATIONS].
    BRUNO A; BOZZI R; ALLEGRANZA A; DEVITO C
    Riv Patol Nerv Ment; 1963 Sep; 84():451-92. PubMed ID: 14153094
    [No Abstract]   [Full Text] [Related]  

  • 33. The urinary elimination of vanillyl mandelic acid and 5-hydroxyindoleacetic acid in healthy Puerto Ricans.
    Suárez RM; Alvarado F; Suárez RM; Olavarrieta S
    Bol Asoc Med P R; 1967 May; 59(5):216-21. PubMed ID: 5232816
    [No Abstract]   [Full Text] [Related]  

  • 34. [Emotional stress and biochemical responses of completely recovered manic depressive patients (author's transl)].
    Nakahara T
    Seishin Shinkeigaku Zasshi; 1981; 83(5):263-74. PubMed ID: 6169103
    [No Abstract]   [Full Text] [Related]  

  • 35. Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study.
    Chouinard G; Young SN; Annable L; Sourkes TL
    Acta Psychiatr Scand; 1979 Apr; 59(4):395-414. PubMed ID: 155389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives.
    Shapira B; Oppenheim G; Zohar J; Segal M; Malach D; Belmaker RH
    Biol Psychiatry; 1985 May; 20(5):576-9. PubMed ID: 2985131
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary monoamine metabolites in children with minimal brain dysfunction.
    Wender PH; Epstein RS; Kopin IJ; Gordon EK
    Am J Psychiatry; 1971 Apr; 127(10):1411-5. PubMed ID: 5549938
    [No Abstract]   [Full Text] [Related]  

  • 38. The switch process from depression to mania: relationship to drugs which alter brain amines.
    Bunney WE; Murphy DL; Goodwin FK; Borge GF
    Lancet; 1970 May; 1(7655):1022-7. PubMed ID: 4191630
    [No Abstract]   [Full Text] [Related]  

  • 39. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biochemical correlates of a 48 hour periodic psychosis].
    Bojanovsky J
    Psychiatr Clin (Basel); 1971; 4(5):336-46. PubMed ID: 5150846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.